Rituximab Rat Monoclonal Antibody [Clone ID: MB2 A4]
Rituximab rat monoclonal antibody, clone MB2 A4, FITC
|Clone Name||MB2 A4|
|Recommended Dilution||Flow Cytometry: Use 10 µl of neat antibody to label 106 cells in 100 µl.|
|Immunogen||F(ab)2 fragment of Rituximab|
|Specificity||This antibody specifically recognizes the idiotypic determinants expressed by the Rituximab humanised monoclonal antibody. This antibody does not recognise other CD20 antibodies.
It has been used to detect Rituximab bound to the surface of the Raji B cell line, however detection of Rituximab bound 'in vivo' to B-CLL cells has not been demonstrated. It is possible that complement deposition on Rituximab opsonised cells inhibits binding of the anti-Rituximab antibody to cell bound Rituximab (3).
|Formulation||PBS, pH 7.4
State: Liquid purified IgG fraction from Tissue Culture Supernatant
Stabilizer: 1% BSA
Preservative: 0.09% Sodium Azide
|Purification||Affinity Chromatography on Protein G|
|Background||Rituximab is a therapeutic reagent directed against the human CD20 cell surface antigen.|